Y. Antero Kesäniemi

Y. Antero Kesäniemi's AcademicInfluence.com Rankings

Y. Antero Kesäniemi

Biology

#12584

World Rank

#16069

Historical Rank

Biochemistry

#2159

World Rank

#2304

Historical Rank

biology Degrees

Download Badge

Biology

Y. Antero Kesäniemi's Degrees

PhD Nutritional Sciences University of Helsinki
Masters Biochemistry University of Helsinki
Bachelors Biochemistry University of Helsinki

Why Is Y. Antero Kesäniemi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Y. Antero Kesäniemi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. (1990) (650)
Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland (1992) (558)
Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. (2003) (524)
Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study (1997) (439)
Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. (1996) (428)
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. (1987) (417)
LDL-cholesterol concentrations: a genome-wide association study (2008) (355)
Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis (2003) (290)
An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report. (2014) (236)
Association of metabolic syndrome with Alzheimer disease (2006) (222)
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects (1999) (217)
Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. (1989) (215)
Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. (1989) (211)
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. (1992) (203)
Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population (1987) (194)
Heart rate variability in systemic hypertension. (1996) (170)
Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables (2002) (155)
Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. (1994) (155)
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. (1994) (149)
Gamma‐glutamyl transpeptidase and the metabolic syndrome (2000) (142)
Identification of a Sudden Cardiac Death Susceptibility Locus at 2q24.2 through Genome-Wide Association in European Ancestry Individuals (2011) (141)
Genome‐wide Linkage and Association Analyses to Identify Genes Influencing Adiponectin Levels: The GEMS Stud (2009) (139)
Cholesteryl ester transfer protein gene effect on CETP activity and plasma high‐density lipoprotein in European populations (1999) (139)
High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. (2006) (138)
Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. (1985) (137)
Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation (2007) (134)
Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. (1995) (132)
Carotid arteriosclerosis in identical twins discordant for cigarette smoking. (1989) (121)
Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. (1996) (119)
Increased high‐density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity (1990) (119)
Low plasma adiponectin concentration is an indicator of the metabolic syndrome. (2006) (118)
A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. (1992) (114)
Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. (1998) (113)
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study) (2015) (110)
Effects of alcohol on lipoproteins in relation to coronary heart disease. (1995) (110)
Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a) (2004) (110)
Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. (2002) (109)
Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. (2004) (105)
Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms (2010) (104)
Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects (2003) (101)
1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. (1994) (101)
Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins. (1985) (100)
Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. (1996) (100)
Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. (2001) (100)
Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. (1991) (98)
ETHANOL AND ACETALDEHYDE IN THE MILK AND PERIPHERAL BLOOD OF LACTATING WOMEN AFTER ETHANOL ADMINISTRATION (1974) (98)
Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. (1993) (96)
Lack of association between polymorphisms of catalase, copper–zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus (2001) (96)
Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study (1996) (96)
Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohort (2002) (95)
The association of apolipoprotein E polymorphism with memory: a population based study (1995) (93)
Influence of probucol on cholesterol and lipoprotein metabolism in man. (1984) (90)
A Natural Antibody to Oxidized Cardiolipin Binds to Oxidized Low-Density Lipoprotein, Apoptotic Cells, and Atherosclerotic Lesions (2006) (89)
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. (2007) (89)
Carbamylation-induced alterations in low-density lipoprotein metabolism. (1992) (88)
Placental and foetal metabolism of acetaldehyde in rat. I. Contents of ethanol and acetaldehyde in placenta and foets of the pregnant rat during ethanol oxidation. (2009) (85)
Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. (1984) (85)
Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. (1995) (84)
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). (2005) (81)
Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis (1996) (81)
The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. (2003) (78)
Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients (2005) (78)
Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. (2008) (78)
Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. (1992) (77)
Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors (1996) (76)
Gallstone cholesterol content is related to apolipoprotein E polymorphism. (1993) (75)
Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. (2002) (73)
Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study (2014) (73)
Baroreflex sensitivity and variants of the renin angiotensin system genes. (2000) (72)
Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. (1999) (70)
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima‐media thickness (2001) (69)
A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men. (1991) (67)
Decreased clearance of uraemic and mildly carbamylated low‐density lipoprotein (1994) (66)
Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males (2006) (66)
Estrogen replacement therapy increases plasma ghrelin levels. (2005) (65)
Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. (2000) (63)
Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? (1996) (61)
Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women. (1995) (60)
Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man (1987) (59)
Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. (1996) (58)
A lineshape fitting model for 1H NMR spectra of human blood plasma (1991) (57)
Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. (2009) (56)
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study (1998) (55)
The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFα (2009) (55)
Low vs high dietary fiber and serum, biliary, and fecal lipids in middle-aged men. (1990) (51)
Plasma homocysteine concentration is decreased by dietary intervention* (2003) (51)
Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. (2008) (50)
Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study. (2012) (50)
ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. (2003) (48)
Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects (2007) (48)
Metabolism of ethanol and acetaldehyde in intact rats during pregnancy. (1974) (48)
Long-term effects of three fat-modified diets in hypercholesterolemic subjects. (1994) (48)
The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes (2005) (48)
Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. (1997) (46)
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs—apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes (2009) (46)
Decreased clearance of low-density lipoprotein in patients with chronic renal failure. (1994) (45)
Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus (2003) (45)
Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism (2001) (45)
Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors (2008) (44)
Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. (1996) (43)
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemias⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional four figures. Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/j (2005) (43)
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. (2017) (42)
Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment. (1995) (42)
Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men (2002) (42)
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. (2007) (42)
APOE-ε4 is associated with weight loss in women with AD (2001) (42)
Effects of estrogen replacement therapy on natriuretic peptides and blood pressure. (2004) (41)
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels. (2000) (40)
Determinants of resting energy expenditure in obese non-diabetic caucasian women (1997) (39)
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. (1998) (39)
Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland (1992) (38)
Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults. (2009) (38)
Sequencing analysis of ghrelin gene 5' flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. (2006) (38)
Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein. (1990) (37)
R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity. (1998) (37)
Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy. (2000) (37)
Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin (2014) (36)
Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis (2008) (36)
The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects (1999) (36)
Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults. (1998) (35)
Placental and foetal metabolism of acetaldehyde in rat. II. Studies on metabolism of acetaldehyde in the isolated placenta and foetus. (2009) (35)
Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity. (1998) (34)
Hyperinsulinemia and Carotid Atherosclerosis in Hypertensive and Control Subjects (1998) (34)
Variants of renin-angiotensin system genes and echocardiographic left ventricular mass. (1998) (34)
Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran (1997) (34)
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. (1995) (34)
Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes (2013) (33)
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer (2000) (33)
Association Analysis of Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Late Onset Alzheimer’s Disease in the Finnish Population (2006) (31)
Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. (2008) (31)
Apolipoprotein B gene DNA polymorphisms are associated with macro‐ and microangiopathy in non‐insulin‐dependent diabetes mellitus (1993) (30)
Cholesterol precursor sterols, plant sterols, and cholestanol in human bile and gallstones. (1986) (30)
Lean-Seafood Intake Reduces Cardiovascular Lipid Risk Factors in Healthy Subjects : Results From A Randomized Controlled Trial With A Crossover Design (2015) (29)
Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. (2007) (29)
Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides (2013) (29)
Multiple changes in apoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men. (1991) (29)
Increased daily sodium intake is an independent dietary indicator of the metabolic syndrome in middle-aged subjects (2012) (28)
ACCURACY COMPARISON OF OSCILLOMETRIC AND ELECTRONIC PALPATION BLOOD PRESSURE MEASURING METHODS USING INTRA-ARTERIAL METHOD AS A REFERENCE (2005) (28)
Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins. (1996) (28)
Apolipoprotein E Phenotype Alone Does Not Influence Survival in Alzheimer’s Disease: A Population-Based Longitudinal Study (2000) (28)
Increased pulse pressure is associated with reduced baroreflex sensitivity (2004) (27)
INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION (2005) (27)
Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease. (2009) (26)
Leptin receptor Lys109Arg and Gln223Arg polymorphisms are associated with early atherosclerosis. (2010) (26)
Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. (1992) (26)
Prognostic significance of impaired baroreflex sensitivity assessed from Phase IV of the Valsalva maneuver in a population-based sample of middle-aged subjects. (2014) (25)
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. (2008) (25)
Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients. (1994) (25)
Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism. (2005) (25)
A comparative study of 1H NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasm (1993) (25)
High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism. (2010) (25)
Plasma adiponectin--an independent indicator of liver fat accumulation. (2011) (24)
Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis (2011) (24)
DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro‐ and microangiopathy in non‐insulin‐dependent diabetes mellitus (1994) (23)
Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation. (2013) (23)
Cardiovascular disease and hyperlipidaemia. (1994) (23)
A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. (1996) (23)
Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study) (2018) (22)
Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy (1997) (22)
Compensatory mechanisms governing the concentration of plasma low density lipoprotein. (1986) (22)
Leptin and lipid metabolism in chronic kidney failure (2009) (22)
Plasma lipid levels and body weight altered by intrauterine growth restriction and postnatal fructose diet in adult rats (2013) (22)
Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. (2013) (21)
Effect of cholecystectomy on plasma lipid and lipoprotein levels. (1995) (21)
APOE-epsilon4 is associated with weight loss in women with AD: a population-based study. (2001) (20)
Dietary and other non‐pharmacological treatments in patients with drug‐treated hypertension and control subjects (2000) (20)
Regulation of low-density lipoprotein apolipoprotein B levels. (1987) (20)
Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects (2009) (20)
Evaluation of plasma cholesteryl ester transfer protein (CETP) activity as a marker of alcoholism. (1992) (19)
Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers. (1997) (19)
Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers. (1998) (19)
Alcohol withdrawal-induced change in lipoprotein(a): association with the growth hormone/insulin-like growth factor-I (IGF-I)/IGF-binding protein-1 (IGFBP-1) axis. (1998) (19)
The effect of a short-term hypocaloric diet on liver gene expression and metabolic risk factors in obese women. (2009) (19)
Low density lipoprotein derivatization by acetaldehyde affects lysine residues and the B/E receptor binding affinity. (1991) (18)
Serum triglycerides and clinical benefit in lipid-lowering trials. (1998) (18)
Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study) (2019) (17)
Sequencing analysis of the ghrelin receptor (growth hormone secretagogue receptor type 1a) gene. (2004) (17)
Metabolism of cholesterol and apolipoprotein B in celiac disease. (1993) (17)
Ghrelin vaccination decreases plasma MCP-1 level in LDLR−/−-mice (2009) (16)
High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study (2014) (15)
Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity. (2009) (15)
Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population (2017) (15)
Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death. (2014) (15)
Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects (2010) (15)
Apolipoprotein E phenotype and diet-induced alteration in blood pressure. (1997) (15)
Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia. (1999) (14)
Risk of dementia associated with the ApoE ɛ4 allele and falls causing head injury without explicit traumatic brain injury (2008) (14)
Muscle fiber type I influences lipid oxidation during low‐intensity exercise in moderately active middle‐aged men (2006) (14)
Variation in the vascular endothelial growth factor gene, carotid intima‐media thickness and the risk of acute myocardial infarction (2009) (13)
IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk. (2017) (13)
The effect of energy restriction during pregnancy on obesity-related peptide hormones in rat offspring (2009) (13)
Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring—a cross-sectional population-based study (2010) (13)
Functional Significance of KCNH2 (HERG) K897T Polymorphism for Cardiac Repolarization Assessed by Analysis of T‐Wave Morphology (2006) (13)
Adiponectin concentration in plasma is associated with muscle fiber size in healthy middle-aged men (2012) (13)
Relationship Between Heart Rate Variability and Cardiovascular Risk Factors in Middle‐Aged Males (1996) (12)
Ghrelin and its promoter variant associated with cardiac hypertrophy (2012) (12)
Two variants in the resistin gene and the response to long-term overfeeding (2004) (12)
Serum ghrelin and the prediction of the development of impaired glucose regulation and Type 2 diabetes in middle-aged subjects. (2010) (12)
Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort (2004) (12)
Biliary lipid secretion in chronic cholestatic liver disease. (1982) (12)
Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study). (2015) (11)
Comparison of Family History of Sudden Cardiac Death in Nonischemic and Ischemic Heart Disease (2012) (11)
Lovastatin enhances hepatic uptake of low density lipoprotein in humans. (1993) (10)
Serum lipids and apolipoprotein E phenotypes in identical twins reared apart1 (1998) (10)
Clofibrate, caloric restriction, supersaturation of bile, and cholesterol crystals. (1983) (10)
Low-density lipoprotein particle composition: what is the contribution to atherogenicity? (2000) (10)
Soluble ST2, a biomarker of fibrosis, is associated with multiple risk factors, chronic diseases and total mortality in the OPERA study (2021) (10)
Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes. (1981) (9)
Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status (2010) (9)
STRUCTURAL CHANGES OF LIPOPROTEIN LIPIDS BY 1H NMR (1995) (9)
Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal. (1999) (9)
ApoE phenotype is associated with inflammatory markers in middle-aged subjects (2009) (8)
Multicentric reticulohistiocytosis, another lipid disorder with normolipidemic xanthomatosis? (1987) (8)
Temporal changes in cardiovascular autonomic regulation in type II diabetic patients: association with coronary risk variables and progression of coronary artery disease (2003) (8)
Low-density lipoprotein clearance in patients with chronic renal failure. (2009) (8)
Cardiac Remodeling from Middle Age to Senescence (2017) (8)
Dietary sodium intake and prediction of cardiovascular events (2015) (8)
Early atherosclerosis and IgG2 to bacteria are associated with FcγRIIa genotype in non‐smokers (2009) (7)
Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up (2018) (7)
Serum ghrelin and the prediction of the development of impaired glucose regulation and Type 2 diabetes in middle-aged subjects (2010) (7)
Regulation of plasma low density lipoprotein levels in postmenopausal women. (2000) (7)
Enhanced cholesterol elimination and synthesis related to low-density lipoprotein metabolism. (1987) (7)
Metabolic epidemiology of plasma cholesterol. (1988) (6)
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus (1995) (6)
Serum ghrelin and prediction of metabolic parameters in over 20-year follow-up (2016) (6)
Effect of a synthetic prostaglandin E2 analogue, RS-86505-007, on plasma lipids and lipoproteins in patients with moderate hypercholesterolaemia: efficacy and tolerance of treatment and response in different apolipoprotein polymorphism groups (2004) (6)
Non-dipping blood pressure pattern and new-onset diabetes in a 21-year follow-up (2019) (6)
Serum lipids and apolipoprotein E phenotypes in identical twins reared apart. (1998) (6)
Effect of simvastatin and ezetimibe on suPAR levels and outcomes. (2018) (5)
Apolipoprotein E phenotype and blood pressure (1994) (5)
Assessment of cholesteryl ester transfer protein function in lipoprotein mixtures by 1H NMR spectroscopy (1997) (5)
Lp(a) levels increase after ethanol withdrawal. (1993) (5)
Biliary secretion of bilirubin and lipids in chronic cholestatic liver disease. (1985) (4)
Resistin is a risk factor for all-cause mortality in elderly Finnish population: A prospective study in the OPERA cohort (2021) (4)
Relevance of the reduction of triglycerides in the prevention of coronary heart disease. (1998) (4)
Peptide hormones in infants with feeding disorders (2013) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up (2017) (4)
Long Telomeres in Blood Leukocytes Are Associated with a High Risk of Ascending Aortic Aneurysm (2012) (4)
Screening for a prevalent LDL receptor mutation in patients with severe hypercholesterolaemia (1991) (3)
Gene Expression Profiles in Fetal and Neonatal Rat Offspring of Energy-Restricted Dams (2010) (3)
Effects of early administration of enalapril on radionuclide left ventricular ejection fraction and plasma N-terminal atrial natriuretic peptide after acute myocardial infarction. (1994) (3)
Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions. (1973) (3)
Association between angiotensin-converting enzyme insertion/deletion polymorphism and treatment response in type 2 diabetic patients. (2006) (3)
Thrombolysis with tissue plasminogen activator enhances serum lipoprotein(a) levels compared to streptokinase and conservative treatment in patients with acute myocardial infarction (1996) (3)
Guidelines for methods to determine efficacy and safety of drugs acting on the gastrointestinal tract. The international union of pharmacology (IUPHAR). (1998) (3)
Life style habits, biochemical factors and their interaction in the prediction of incident hypertension during 21-year follow-up (2018) (3)
Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes (2005) (3)
[Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary]. (2014) (2)
Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole (2011) (2)
Pathophysiology of low density lipoprotein and high density lipoprotein glucosylation. (1985) (2)
Apolipoprotein E phenotypes and response to dietary fat and cholesterol. (1996) (2)
Peptide hormones and risk for future cardiovascular events among prediabetics: a 20-year follow-up in the OPERA study (2020) (2)
Low Density Lipoprotein in Man QUANTITATION USING GLUCOSYLATED LOW DENSITY LIPOPROTEIN (1983) (1)
Apolipoproteins and gallstone disease. (1995) (1)
GENE EXPRESSION CHANGES INDUCED BY FETAL UNDERNUTRITION IN RAT (2008) (1)
Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions. (1973) (1)
Dyslipidemic syndromes and atherosclerosis: recent advances and challenges for the future (1995) (1)
Hypertension, plasma lipids and antihypertensive drugs. (1991) (1)
Apolipoprotein E, alcohol, and blood pressure: reply to Puddey et al. (1999) (1)
Responses of blood glucose and serum insulin to peroral glucose load in normoglycemic twins. (1984) (1)
Mechanisms of low density lipoprotein lowering by hypolipidemic agents. (1991) (1)
Kinetic Analysis of Lipoproteins-Reply (1985) (0)
Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole (2005) (0)
Glomerular filtration rate and serum phosphate : an inverse relationship diluted by age (2009) (0)
Subject Index Vol. 19, 2000 (2000) (0)
EFFECTS OF GHRELIN IN MONOCYTE ADHESION TO ENDOTHELIAL CELLS AND BINDING OF OXIDIZED LDL ON MACROPHAGES (2008) (0)
PO22-703 EFFECTS OF GHRELIN VACCINATION IN MICE (2007) (0)
PO19-519 PLASMA IL-5 LEVELS ARE ASSOCIATED WITH ANTIBODIES TO OXIDIZED LDL AND SUBCLINICAL ATHEROSCLEROSIS IN HUMANS (2007) (0)
Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides (2013) (0)
4.P.349 Effect of alcohol-induced changes in plasma lipoproteins and lipids on cholesteryl ester transfer (1997) (0)
In Memoriam: Tatu A. Miettinen (1930-2011) (2012) (0)
Genetics and cholesterol metabolism (1996) (0)
648 THE EFFECT OF FETAL UNDERNUTRITION ON GLUCOSE METABOLISM IN RAT OFFSPRING (2011) (0)
Prevalence and prognosis of subjects with brugada-type ECG pattern in a young and middle-aged finnish population ☆ (2004) (0)
Paper594-21 feb 1998 (1998) (0)
ISNN Society News (2009) (0)
[Alcohol consumption and coronary heart disease in Finland]. (1991) (0)
PO9-242 PRESENCE OF IGG ANTIBODIES TO CARBAMYLATED PROTEINS ARE RELATED TO ANTIBODIES BINDING TO APOPTOTIC CELLS (2007) (0)
Cholesterol and Bile Acid Synthesis as Related to Receptor and Non-receptor Mediated Degradation of LDL in Man (1986) (0)
ISNN Membership Application Form (2007) (0)
Effect of ethanol on the rate of elimination of galactose in women during the puerperium. (1973) (0)
647 THE EFFECTS OF FETAL UNDERNUTRITION ON THE GENE EXPRESSION OF WHITE ADIPOSE TISSUE IN RAT (2011) (0)
PO22-688 EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON PLASMA ADIPONECTIN AND RESISTIN CONCENTRATIONS IN HYSTERECTOMIZED POSTMENOPAUSAL WOMEN (2007) (0)
Symposium Drugs Effecting Cholesterol Disposition (1983) (0)
Contents Vol. 19, 2000 (2000) (0)
Contents Vol. 22, 2006 (2006) (0)
THE EFFECT OF CALORIC RESTRICTION ON OBESITY-RELATED PEPTIDE HORMONES IN RAT (2008) (0)
Subject Index Vol. 22, 2006 (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Y. Antero Kesäniemi?

Y. Antero Kesäniemi is affiliated with the following schools:

University of Turku
University of Oulu
University of Helsinki